Literature DB >> 23337036

Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.

Navjot Kaur1, Sivarajan Chettiar, Sachin Rathod, Phalguni Rath, Dattatraya Muzumdar, M L Shaikh, Anjali Shiras.   

Abstract

Presence of a distinct population of cells that drives tumor progression supports the hierarchical model of tumor development in Glioblastoma (GBM) and substantiates the cancer stem cell hypothesis. Amongst the various developmental signaling pathways that are aberrantly activated, we here show that activated Wnt/β-catenin signaling pathway plays a critical role in malignant transformation and tumor progression in gliomas. We demonstrate that Wnt ligands - Wnt1 and Wnt3a are expressed in a graded manner in these tumors as well as over-expressed in glioma stem cell-lines. A selective inhibition of Wnt signaling pathway by selective knock-down of its ligands Wnt1 and Wnt3a in glioma-derived stem-like cells led to decreased cell proliferation, cell migration and chemo-resistance. Furthermore, Wnt silencing in glioma cells reduced the capacity to form intra-cranial tumors in vivo. Taken together, our study indicates Wnt/β-catenin signaling pathway as an essential driver of glioma tumorigenesis, recognizing role of Wnt3a as an oncogene and thereby offering novel therapeutic strategies for management of these tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337036     DOI: 10.1016/j.mcn.2013.01.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  59 in total

1.  Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

Authors:  De-Chen Lin; Liang Xu; Ye Chen; Haiyan Yan; Masaharu Hazawa; Ngan Doan; Jonathan W Said; Ling-Wen Ding; Li-Zhen Liu; Henry Yang; Shizhu Yu; Michael Kahn; Dong Yin; H Phillip Koeffler
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

2.  Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.

Authors:  Mireia Nàger; Marta C Sallán; Anna Visa; Charumathi Pushparaj; Maria Santacana; Anna Macià; Andrée Yeramian; Carles Cantí; Judit Herreros
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

Review 3.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

4.  GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.

Authors:  Diana Matias; Luiz Gustavo Dubois; Bruno Pontes; Luciane Rosário; Valeria Pereira Ferrer; Joana Balça-Silva; Anna Carolina Carvalho Fonseca; Lucy Wanjiku Macharia; Luciana Romão; Tania Cristina Leite de Sampaio E Spohr; Leila Chimelli; Paulo Niemeyer Filho; Maria Celeste Lopes; José Garcia Abreu; Flavia Regina Souza Lima; Vivaldo Moura-Neto
Journal:  Mol Neurobiol       Date:  2018-06-14       Impact factor: 5.590

5.  Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.

Authors:  Jennillee Wallace; Srinivas D Narasipura; Beverly E Sha; Audrey L French; Lena Al-Harthi
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

6.  Wnt3a expression is associated with poor prognosis of esophageal squamous cell carcinoma.

Authors:  Junya Oguma; Soji Ozawa; Akihito Kazuno; Miho Nitta; Yamato Ninomiya; Hiroshi Kajiwara
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

Review 7.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

Review 8.  Multiple oncogenic roles of nuclear beta-catenin.

Authors:  Raju Kumar; Murali D Bashyam
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

9.  Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.

Authors:  Liuhong Pan; Min Yao; Wenjie Zheng; Juanjuan Gu; Xuli Yang; Liwei Qiu; Yin Cai; Wei Wu; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-11-17

10.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.